AACR 2026

April 17-22, 2026
San Diego, CA

American Association for Cancer Research Annual Meeting

Explore more Oncology congress materials

Results(3)

Oncology

AACR Adaptive Biomarker-Driven Organ Preservation Trial in Gastroesophageal Adenocarcinomas (AACR-ADOPT-GEA

Author(s): Elimova E, Ajani JA, Klempner SJ et al.

A Phase 2 Single-Arm Open-Label Trial Evaluating Zanidatamab in Patients with Early Stage HER2- positive Breast Cancer: The NeoZanHER Study

Author(s): Vicente Valero, Paula R. Pohlmann, Jason Mouabbi et al.

Zanidatamab modulates multiple pathways involved in tumor growth and survival and is efficacious post–T-DXd

Author(s): Ankur Karmokar, Emanuele Loro, Al Hassan Kyakulaga et al.

Disclaimer

This AI model is continuing to learn and its responses are based on learned data patterns. It should not replace professional judgment. Please verify the information before use, and feedback is welcome to improve its accuracy.

Please do not include personal or confidential information in your searches. For information on how to report an adverse event or product complaint for a Jazz product, please visit: https://www.jazzpharma.com/medicines/drug-safety/.